No compromise:
Macopharma bans DEHP, to ensure SAFE and SECURED
blood component solutions to every patient in the world!
More than words, we commit to act and respect our mission:
We support life !
At Macopharma,
we consider Non DEHP
transition as INNOVATION.
we consider Non DEHP
transition as INNOVATION.
Because the value of future bag systems is about safety
we have dedicated a full team of scientific experts to research,
design and develop our new kits as a pure
INNOVATION.
About REACH regulation
REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) is a regulation of the European Union, adopted to improve the protection of human health and the environment from the risks that can be posed by chemicals.(1)
(1) European Chemicals Agency. Understanding REACH. Available at: https://echa.europa.eu/regulations/reach/understanding-reach Accessed July 2022.
About DEHP
Used for decades, DEHP has a positive effect on the red blood cell membrane integrity and reduces the hemolysis. But the listed toxicological effects have to be considered:(1,2)
(1) Horowitz B, Stryker MH, Waldman AA, Woods KR, Gass JD, Drago J. Stabilization of red blood cells by the plasticizer, diethylhexylphthalate. Vox Sang 1985; 48:150-5.
(2) AuBuchon JP, Estep TN, Davey RJ. The effect of the plasticizer di-2-ethylhexyl phthalate on the survival of stored RBCs. Blood 1988; 71:448-52.
CHOOSING the best SOLUTION :
DEHT x PAGGS-M*
DEHT x PAGGS-M*
* Di(ethylhexyl) terephthalate / phosphate-adenine-glucose-guanosin-saline-mannitol
DEHT has an improved safety profile with no reported mutagenic, carcinogenic or reproductive effects(1,2)
PAGGS-M improves red cell concentrate quality parameters with no reported impact on clinical effectiveness or patient safety(3,4)
DEHT versus DEHP
DEHT x PAGGS-M
(1)Kambia Metabolites 2021; 11:94.
(2)Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR). Opinion on the safety of medical devices containing DEHP plasticised PVC or other plasticisers on neonates and other groups possibly at risk (2015 update). 2017.
(3)Larsson L. Vox Sang. 2021;116:60-70
(4)Flegel WA. Br J Haematol. 2014;165(1):3-16.
(5)Graminske, Transfusion 2018; 58:1100-7.
(6)Hess J. Extended Liquid Storage of Red Blood Cells. In: Manning FJ, Sparacino L, Eds. Blood Donors and the Supply of Blood and Blood Products. Washington DC: The National Academies Press, 1996.
